Combined IL-12 Receptor and IgA Deficiency in an Adult Man Intestinally Infested by an Unknown, Non-Cultivable Mycobacterium

Scandinavian Journal of Immunology

Volumn 74, Issue 6, 2011, Pages 548-553

  Schejbel, L ^a   Rasmussen, E M ^b   Kemp, H B ^a   Lundstedt, A C ^a   Nielsen, K R ^c   Obel, N ^a   Marquart, H ^a   Andersen, A B ^a,d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c Landssjúkrahúsi ^*  (Faroe Islands)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT; CEPHALOSPORIN; CLARITHROMYCIN; ETHAMBUTOL; GAMMA INTERFERON; INTERLEUKIN 12 RECEPTOR; RIFAMPICIN; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ABDOMINAL PAIN; ADULT; ARTICLE; CASE REPORT; DIARRHEA; DISEASE PREDISPOSITION; DRUG MEGADOSE; GASTROINTESTINAL DISEASE; GENE MUTATION; HETEROZYGOSITY; HOMEOSTASIS; HUMAN; IMMUNOGLOBULIN A DEFICIENCY; INFESTATION; MALE; MYCOBACTERIUM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SALMONELLOSIS; WEIGHT REDUCTION;

BASE SEQUENCE; BIOPSY; FEMALE; HUMANS; IGA DEFICIENCY; INTERFERON-GAMMA; INTESTINAL DISEASES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; RECEPTORS, INTERLEUKIN-12; SEQUENCE ALIGNMENT;

EID: 81255147196     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2011.02603.x     Document Type: Article

References (16)

1. Amsen D, Spilianakis CG, Flavell RA. How are T(H)1 and T(H)2 effector cells made? Curr Opin Immunol 2009;21:153-60.
2. de BL, Puel A, Filipe-Santos O et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med 2008;205:1543-50.
3. Sanal O, Turul T, De BT et al. Presentation of interleukin-12/-23 receptor beta1 deficiency with various clinical symptoms of Salmonella infections. J Clin Immunol 2006;26:1-6.
4. Al-Muhsen S, Casanova JL. The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol 2008;122:1043-51.
5. de Beaucoudrey L, Samarina A, Bustamante J et al. Revisiting human IL-12Rb1 deficiency: a survey of 141 patients from 30 countries. Medicine 2010;89:381-402.
6. Storgaard M, Varming K, Herlin T, Obel N. Novel mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infections. Scand J Immunol 2006;64:137-9.
7. Dorman SE, Holland SM. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest 1998;101:2364-9.
8. Weber-Mzell D, Kotanko P, Hauer AC et al. Gender, age and seasonal effects on IgA deficiency: a study of 7293 Caucasians. Eur J Clin Invest 2004;34:224-8.
9. Yel L. Selective IgA deficiency. J Clin Immunol 2010;30:10-6.
10. Brandtzaeg P. Update on mucosal immunoglobulin A in gastrointestinal disease. Curr Opin Gastroenterol 2010;26:554-63.
11. Heyworth MF. Intestinal IgA responses to Giardia muris in mice depleted of helper T lymphocytes and in immunocompetent mice. J Parasitol 1989;75:246-51.
12. Rodriguez A, Tjarnlund A, Ivanji J et al. Role of IgA in the defense against respiratory infections IgA deficient mice exhibited increased susceptibility to intranasal infection with Mycobacterium bovis BCG. Vaccine 2005;23:2565-72.
13. Reljic R, Williams A, Ivanyi J. Mucosal immunotherapy of tuberculosis: is there a value in passive IgA? Tuberculosis 2006;86:179-90.
14. Williams A, Reljic R, Naylor I et al. Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs. Immunology 2004;111:328-33.
15. Bekou V, Buchau A, Flaig MJ, Ruzicka T, Hogardt M. Cutaneous infection by Mycobacterium haemophilum and kansasii in an IgA-deficient man. BMC Dermatol 2011;11:3.
16. Fieschi C, Dupuis S, Catherinot E et al. Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications. J Exp Med 2003;197:527-35.